ID
37142
Description
Study ID: 104864/502 Clinical Study ID: 104864/502 Study Title: An Open-Label, Multicenter, Randomized, Phase II Study of Oral Topotecan Daily x 5 Days vs. Oral Topotecan 5 Days On, 2 Days Off for 3 Weeks for Second-Line Treatment in Patients with Recurrent, Locally Advanced or Metastatic Cervical Cancer Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Topotecan Trade Name: N/A Study Indication: Cancer, Locally Advanced or Metastatic Cervical Cancer
Keywords
Versions (1)
- 7/4/19 7/4/19 -
Copyright Holder
GlaxoSmithKline
Uploaded on
July 4, 2019
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Oral Topotecan Daily x 5 Days vs. Oral Topotacan 5 Days On, 2 Days Off; 104864/502
Post-Study Minimal Follow-Up Report
- StudyEvent: ODM
Description
Month of Report
Alias
- UMLS CUI-1
- C1704685
- UMLS CUI-2
- C0439231
Description
Follow-Up Report, Month
Data type
text
Alias
- UMLS CUI [1,1]
- C1704685
- UMLS CUI [1,2]
- C0439231
Description
Follow-Up Report, Month
Data type
text
Alias
- UMLS CUI [1,1]
- C1704685
- UMLS CUI [1,2]
- C0439231
Description
Outcome
Alias
- UMLS CUI-1
- C1547647
Description
Cessation of life
Data type
boolean
Alias
- UMLS CUI [1]
- C0011065
Description
Date last contact
Data type
date
Alias
- UMLS CUI [1]
- C0805839
Description
Disease Progression
Data type
text
Alias
- UMLS CUI [1]
- C0242656
Description
Disease Progression, Start Date
Data type
date
Alias
- UMLS CUI [1,1]
- C0242656
- UMLS CUI [1,2]
- C0808070
Description
cancer treatment, post, Clinical Trials
Data type
text
Alias
- UMLS CUI [1,1]
- C0920425
- UMLS CUI [1,2]
- C0032756
- UMLS CUI [1,3]
- C0008976
Description
cancer treatment, post, Clinical Trials, Start Date
Data type
date
Alias
- UMLS CUI [1,1]
- C0920425
- UMLS CUI [1,2]
- C0032756
- UMLS CUI [1,3]
- C0008976
- UMLS CUI [1,4]
- C0808070
Description
Form D
Alias
- UMLS CUI-1
- C0011065
Description
Cause of death
Data type
text
Alias
- UMLS CUI [1]
- C0007465
Description
Cause of death
Data type
text
Alias
- UMLS CUI [1]
- C0007465
Description
Date of death
Data type
date
Alias
- UMLS CUI [1]
- C1148348
Description
Autopsy
Data type
boolean
Alias
- UMLS CUI [1]
- C0004398
Description
Autopsy, Finding, Diagnosis
Data type
text
Alias
- UMLS CUI [1,1]
- C0004398
- UMLS CUI [1,2]
- C0243095
- UMLS CUI [1,3]
- C0011900
Description
I certify that I have reviewed the follow-up data and that all information is complete and accurate
Data type
text
Alias
- UMLS CUI [1,1]
- C0011065
- UMLS CUI [1,2]
- C2346576
Description
Cessation of life, Investigator Signature, Date in time
Data type
date
Alias
- UMLS CUI [1,1]
- C0011065
- UMLS CUI [1,2]
- C2346576
- UMLS CUI [1,3]
- C0011008
Similar models
Post-Study Minimal Follow-Up Report
- StudyEvent: ODM
C0600091 (UMLS CUI [1,2])
C0439231 (UMLS CUI [1,2])
C0439231 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,2])
C0032756 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0032756 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0808070 (UMLS CUI [1,4])
C0243095 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,3])
C2346576 (UMLS CUI [1,2])
C2346576 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])